In8Bio (INAB) Market Capitalization (2021 - 2026)

In8Bio has disclosed Market Capitalization across 6 years of filings, most recently posting $27.4 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 222.04% year-over-year to $27.4 million; the TTM figure through Jun 2026 stood at $27.4 million (up 222.04% YoY), while the FY2025 annual figure was $10.2 million, down 25.61% from the prior year.
• Market Capitalization came in at $27.4 million for Q2 2026 at In8Bio, down from $28.8 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $62.6 million in Q1 2022 to a low of $8.5 million in Q2 2025.
• Average Market Capitalization over 5 years is $32.3 million, with a median of $32.8 million recorded in 2023.
• Year-over-year, Market Capitalization slumped 78.33% in 2025 and surged 222.04% in 2026.
• Over 5 years, Market Capitalization stood at $56.7 million in 2022, then retreated by 27.31% to $41.2 million in 2023, then slumped by 66.61% to $13.8 million in 2024, then retreated by 25.61% to $10.2 million in 2025, then soared by 168.16% to $27.4 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $27.4 million in Q2 2026, $28.8 million in Q1 2026, and $10.2 million in Q4 2025.